236 related articles for article (PubMed ID: 20425414)
1. Natural killer-cell neoplasms.
Greer JP; Mosse CA
Curr Hematol Malig Rep; 2009 Oct; 4(4):245-52. PubMed ID: 20425414
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
Cheung MM; Chan JK; Wong KF
Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorders of natural killer cells.
Oshimi K
Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
[TBL] [Abstract][Full Text] [Related]
4. Progress in understanding and managing natural killer-cell malignancies.
Oshimi K
Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
6. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
Kwong YL
J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.
Suzuki R; Suzumiya J; Nakamura S; Kagami Y; Kameoka JI; Sakai C; Mukai H; Takenaka K; Yoshino T; Tsuzuki T; Sugimori H; Kawa K; Kodera Y; Oshimi K;
Bone Marrow Transplant; 2006 Feb; 37(4):425-31. PubMed ID: 16400344
[TBL] [Abstract][Full Text] [Related]
12. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
13. The pathology of NK-cell lymphomas and leukemias.
Nava VE; Jaffe ES
Adv Anat Pathol; 2005 Jan; 12(1):27-34. PubMed ID: 15614162
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
[TBL] [Abstract][Full Text] [Related]
15. Leukemia and lymphoma of natural killer lineage cells.
Oshimi K
Int J Hematol; 2003 Jul; 78(1):18-23. PubMed ID: 12894846
[TBL] [Abstract][Full Text] [Related]
16. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.
Lima M
Orphanet J Rare Dis; 2013 Jul; 8():95. PubMed ID: 23816348
[TBL] [Abstract][Full Text] [Related]
17. NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.
Suzuki R
Curr Oncol Rep; 2012 Oct; 14(5):395-402. PubMed ID: 22639106
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell neoplasms.
Tse E; Liang RH
Clin Lymphoma; 2004 Dec; 5(3):197-201. PubMed ID: 15636697
[TBL] [Abstract][Full Text] [Related]
19. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
20. Therapy of peripheral T/NK neoplasms.
Greer JP
Hematology Am Soc Hematol Educ Program; 2006; ():331-7. PubMed ID: 17124080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]